Ramírez-Plascencia Oscar Daniel, Saderi Nadia, Cárdenas-Romero Skarleth, García-García Fabio, Peña-Escudero Carolina, Flores-Sandoval Omar, Azuara-Álvarez Lucia, Báez-Ruiz Adrián, Salgado-Delgado Roberto
Departamento de Fisiología Celular, Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico.
Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Front Neurosci. 2022 Jul 22;16:907508. doi: 10.3389/fnins.2022.907508. eCollection 2022.
Epidemiological and experimental evidence recognize a relationship between sleep-wake cycles and adiposity levels, but the mechanisms that link both are not entirely understood. Adipose tissue secretes adiponectin and leptin hormones, mainly involved as indicators of adiposity levels and recently associated to sleep. To understand how two of the main adipose tissue hormones could influence sleep-wake regulation, we evaluated in male rats, the effect of direct administration of adiponectin or leptin in the ventrolateral preoptic nuclei (VLPO), a major area for sleep promotion. The presence of adiponectin (AdipoR1 and AdipoR2) and leptin receptors in VLPO were confirmed by immunohistochemistry. Adiponectin administration increased wakefulness during the rest phase, reduced delta power, and activated wake-promoting neurons, such as the locus coeruleus (LC), tuberomammillary nucleus (TMN) and hypocretin/orexin neurons (OX) within the lateral hypothalamus (LH) and perifornical area (PeF). Conversely, leptin promoted REM and NREM sleep, including increase of delta power during NREM sleep, and induced c-Fos expression in VLPO and melanin concentrating hormone expressing neurons (MCH). In addition, a reduction in wake-promoting neurons activity was found in the TMN, lateral hypothalamus (LH) and perifornical area (PeF), including in the OX neurons. Moreover, leptin administration reduced tyrosine hydroxylase (TH) immunoreactivity in the LC. Our data suggest that adiponectin and leptin act as hormonal mediators between the status of body energy and the regulation of the sleep-wake cycle.
流行病学和实验证据表明睡眠-觉醒周期与肥胖水平之间存在关联,但两者之间的联系机制尚未完全明确。脂肪组织会分泌脂联素和瘦素等激素,这些激素主要作为肥胖水平的指标,并且最近发现与睡眠有关。为了了解这两种主要的脂肪组织激素如何影响睡眠-觉醒调节,我们在雄性大鼠中评估了向腹外侧视前核(VLPO)直接注射脂联素或瘦素的效果,VLPO是促进睡眠的主要区域。通过免疫组织化学证实了VLPO中存在脂联素(AdipoR1和AdipoR2)和瘦素受体。注射脂联素会增加休息期的清醒时间,降低δ波功率,并激活促进清醒的神经元,如下丘脑外侧区(LH)和穹窿周区(PeF)内的蓝斑(LC)、结节乳头体核(TMN)和下丘脑泌素/食欲素神经元(OX)。相反,瘦素会促进快速眼动睡眠和非快速眼动睡眠,包括增加非快速眼动睡眠期间的δ波功率,并诱导VLPO和表达黑色素浓缩激素的神经元(MCH)中c-Fos的表达。此外,在TMN、下丘脑外侧区(LH)和穹窿周区(PeF),包括OX神经元中,发现促进清醒的神经元活动减少。此外,注射瘦素会降低LC中酪氨酸羟化酶(TH)的免疫反应性。我们的数据表明,脂联素和瘦素作为身体能量状态与睡眠-觉醒周期调节之间的激素介质发挥作用。